Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011		Sep. 30, 2012		Sep. 30, 2011
Interest and dividend income:
Loans	$ 52,533		$ 53,043		$ 157,882		$ 160,190
Taxable investment securities	890		1,456		3,225		4,230
Non-taxable investment securities	782		905		2,382		2,922
Mortgage-backed securities	1,537		1,873		4,743		5,521
Federal funds sold and other	290		242		511		842
Total interest and dividend income	56,032		57,519		168,743		173,705
Interest expense:
Deposits	4,206		5,921		13,544		18,871
Federal Home Loan Bank borrowings	3,501		4,203		11,193		12,856
Junior subordinated debentures	1,507		1,851		4,950		5,648
Repurchase agreements and other short-term borrowings	452		485		1,326		1,526
Total interest expense	9,666		12,460		31,013		38,901
Net interest income	46,366		45,059		137,730		134,804
Provision/ (Credit) for loan losses	(4,000)		4,500		1,700		15,660
Net interest income/(loss) after provision for loan losses	50,366		40,559		136,030		119,144
Fees and other income:
Investment management and trust fees	15,906		16,161		46,628		48,581
Wealth advisory fees	9,495		8,623		27,914		25,672
Other banking fee income	1,250		1,339		3,250		3,859
Gain on repurchase of debt	976		0		2,570		1,838
Gain on sale of investments, net	25		103		878		689
Gain on sale of loans, net	648		386		1,499		1,897
Gain/(loss) on OREO, net	(104)		3,156		221		4,110
Other	408		(44)		1,107		2,186
Total fees and other income	28,604		29,724		84,067		88,832
Operating expense:
Salaries and employee benefits	34,688		33,796		106,071		104,207
Occupancy and equipment	8,078		7,519		23,274		22,079
Professional services	3,455		3,634		9,415		14,062
Marketing and business development	1,346		1,473		4,454		4,770
Contract services and data processing	1,446		1,150		3,989		3,503
Amortization of intangibles	1,082		1,124		3,263		3,679
FDIC insurance	1,138		1,356		2,969		4,887
Restructuring expense	3,581		1,116		4,280		7,402
Other	3,336		3,748		11,397		11,298
Total operating expense	58,150	[1]	54,916	[1]	169,112	[1]	175,887	[1]
Income/(loss) before income taxes	20,820		15,367		50,985		32,089
Income tax expense/(benefit)	5,124		4,542		14,215		8,559
Net income/(loss) from continuing operations	15,696		10,825		36,770		23,530
Net income from discontinued operations	1,672		1,594		5,816		4,810
Net income/ (loss) before attrubution to noncontrolling interests	17,368		12,419		42,586		28,340
Net income/ (loss) attributable to noncontrolling interests	855		740		2,407		2,265
Net income/ (loss) attributable to the Company	16,513	[2]	11,679	[2]	40,179	[2]	26,075	[2]
Adjustments to net income/(loss) attributable to the Company to arrive at net income/(loss) attributable to common shareholders	2,067		1,452		4,582		3,287
Net Income (Loss) Available to Common Shareholders, Basic	$ 14,446		$ 10,227		$ 35,597		$ 22,788
Basic earnings/(loss) per share attributable to common shareholders:
From continuing operations:	$ 0.17		$ 0.12		$ 0.40		$ 0.25
From discontinued operations:	$ 0.02		$ 0.02		$ 0.07		$ 0.06
Total attributable to common shareholders:	$ 0.19		$ 0.14		$ 0.47		$ 0.30
Diluted earnings/(loss) per share attributable to common shareholders:
From continuing operations:	$ 0.17		$ 0.12		$ 0.39		$ 0.25
From discontinued operations:	$ 0.02		$ 0.02		$ 0.07		$ 0.06
Total attributable to common shareholders:	$ 0.19		$ 0.14		$ 0.46		$ 0.30
Common Stock [Member]
Basic earnings/(loss) per share attributable to common shareholders:
Weighted Average Basic Common Shares Outstanding	76,290,382		75,378,923		75,911,520		75,083,976
Diluted earnings/(loss) per share attributable to common shareholders:
Weighted average diluted common shares outstanding	77,367,611	[3]	75,580,877	[3]	76,814,203	[3]	75,259,271	[3]

[1] Non-interest expense for the three and nine months ended September 30, 2012 includes $3.6 million and $4.3 million, respectively, of restructuring expense. Non-interest expense for the three and nine months ended September 30, 2011 includes $1.1 million and $7.4 million, respectively, of restructuring expense. Restructuring expenses have been incurred in the Private Banking segment as well as at the Holding Company.

[2] Net income from discontinued operations for the three months ended September 30, 2012, and 2011 of $1.7 million, and $1.6 million, respectively, and for the nine months ended September 30, 2012, and 2011, of $5.8 million and $4.8 million, respectively, are included in Holding Company and Eliminations in the calculation of net loss attributable to the Company.

[3] (2)The diluted EPS computations for the three and nine months ended September 30, 2012 and 2011 do not assume the conversion, exercise, or contingent issuance of the following shares for these periods because the result would have been anti-dilutive for the periods indicated. As a result of the anti-dilution, the potential common shares excluded from the diluted EPS computation are as follows: Three months ended September 30, Nine months ended September 30, 2012 2011 2012 2011Shares excluded due to anti-dilution (treasury method):(In thousands)Potential common shares from: Convertible trust preferred securities (a)784 1,707 784 1,707Total shares excluded due to anti-dilution784 1,707 784 1,707 Three months ended September 30, Nine months ended September 30, 2012 2011 2012 2011Shares excluded due to exercise price exceeding the average market price of common shares during the period (total outstanding):(In thousands)Potential common shares from: Stock options, performance-based restricted stock, or other dilutive securities (b)2,102 3,967 2,180 3,834Warrants (c)— 2,888 — 2,888Total shares excluded due to exercise price exceeding the average market price of common shares during the period2,102 6,855 2,180 6,722(a) If the effect of the conversion of the trust preferred securities would have been dilutive, interest expense, net of tax, related to the convertible trust preferred securities of $0.2 million and $0.4 million for the three months ended September 30, 2012 and 2011, respectively, and of $0.8 million and $1.2 million for the nine months ended September 30, 2012 and 2011, respectively, would have been added back to net income/ (loss) attributable to common shareholders for diluted EPS computations for the periods presented.(b)Options to purchase shares of common stock, non-participating (performance-based) restricted stock, and other dilutive securities that were outstanding at period ends were not included in the computation of diluted EPS or in the above anti-dilution table because their exercise or conversion prices were greater than the average market price of the common shares during the respective periods. (c)Certain warrants to purchase shares of common stock that were outstanding at period ends were not included in the computations of diluted EPS because the warrants' exercise price was greater than the average market price of the common shares during the respective period. See Part II. Item 8. “Financial Statements and Supplementary Data—Note 27: Subsequent Events” in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 for a discussion of the 2012 repurchase of the Carlyle warrants and the Director's warrants.